Ildiko Csiki, M.D., Ph.D., serves as the chief commercial research and development (R&D) officer at City of Hope, a world-renowned independent research and treatment center for cancer, diabetes and other life-threatening diseases, where she oversees the next generation of a translational biotech-like R&D arm. With over two decades of leadership experience in oncology R&D, Csiki most recently served as the chief medical officer at Sensei Biotherapeutics, where she helped advance the discovery and development of cancer immunotherapies. Csiki began her post-graduate career at the University of Pennsylvania as a tenure-track physician scientist in the Department of Radiation Oncology. She holds an M.D. and Ph.D. in cancer biology from Vanderbilt University School of Medicine.